Aurinia Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ CA05156V1022

SecurityAUPH / Aurinia Pharmaceuticals Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership452,104 shares
Latest Disclosed Value $ 6,700,181
Jane Street Group, Llc ownership in AUPH / Aurinia Pharmaceuticals Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 452,104 shares of Aurinia Pharmaceuticals Inc. (US:AUPH) valued at $6,700,181 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 910,737 shares of Aurinia Pharmaceuticals Inc.. This represents a change in shares of -50.36% during the quarter. The current value of the position is $7,084,470 USD.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (AUPH) in the form of stock options. The firm currently holds call options representing 85,600 of underlying shares valued at $1,268,592 USD and put options representing 19,500 of underlying shares valued at $288,990 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AUPH / Aurinia Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 452,104 -458,633 -50.36 6,700 -53.88 0.0004
2026-02-12 2025-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 910,737 233,484 34.48 14,526 94.12 0.0022
2025-11-14 2025-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 677,253 210,626 45.14 7,484 89.35 0.0011
2025-08-14 2025-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 466,627 154,071 49.29 3,952 57.32 0.0008
2025-05-19 2025-03-31 13F/A-1 AURINIA PHARMACEUTICALS COM 05156V102 312,556 89,911 40.38 2,513 25.66 0.0006
2025-05-14 2025-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 312,556 89,911 2,513 0.0005
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 222,645 -241,356 -52.02 1,999 -41.22 0.0004
2024-11-15 2024-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 464,001 216,773 87.68 3,401 141.03 0.0008
2024-08-15 2024-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 247,228 137,412 125.13 1,412 156.55 0.0003
2024-05-16 2024-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 109,816 -472,671 -81.15 550 -89.50 0.0001
2024-02-15 2023-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 582,487 283,030 94.51 5,237 125.11 0.0014
2023-11-15 2023-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 299,457 -70,302 -19.01 2,327 -35.01 0.0008
2023-08-14 2023-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 369,759 3,333 0.91 3,579 -10.88 0.0012
2023-05-16 2023-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 366,426 232,868 174.36 4,016 597.22 0.0016
2023-02-15 2022-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 133,558 -272,433 -67.10 577 -81.13 0.0003
2022-11-15 2022-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 405,991 -183,105 -31.08 3,053 -48.44 0.0013
2022-08-16 2022-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 589,096 250,115 73.78 5,921 41.11 0.0025
2022-05-17 2022-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 338,981 -148,886 -30.52 4,196 -62.39 0.0014
2022-02-15 2021-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 487,867 136,431 38.82 11,157 93.56 0.0037
2021-11-16 2021-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 351,436 71,466 25.53 5,764 58.88 0.0020
2021-08-16 2021-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 279,970 249,859 829.79 3,628 827.88 0.0014
2021-05-18 2021-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 30,111 -220,972 -88.01 391 -88.74 0.0002
2021-02-17 2020-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 251,083 103,090 69.66 3,473 59.31 0.0017
2020-11-17 2020-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 147,993 40,817 38.08 2,180 25.14 0.0013
2020-08-17 2020-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 107,176 107,176 1,742 0.0013
2020-05-15 2020-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -26,024 -100.00 0 -100.00
2020-02-14 2019-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 26,024 26,024 527 0.0007
2019-02-14 2018-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -27,358 -100.00 0 -100.00
2018-11-14 2018-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 27,358 27,358 182 0.0004
2018-02-15 2017-12-31 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -10,041 -100.00 0 -100.00
2017-11-14 2017-09-30 13F AURINIA PHARMACEUTICALS COM 05156V102 10,041 10,041 63 0.0002
2017-08-14 2017-06-30 13F AURINIA PHARMACEUTICALS COM 05156V102 0 -21,113 -100.00 0 -100.00
2017-05-15 2017-03-31 13F AURINIA PHARMACEUTICALS COM 05156V102 21,113 21,113 155 0.0007
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F AURINIA PHARMACEUTICALS COM Call 85,600 -79.12 1,269 -80.60 n/a n/a n/a
2026-02-12 2025-12-31 13F AURINIA PHARMACEUTICALS COM Call 409,900 4.30 6,538 50.55 n/a n/a n/a
2025-11-14 2025-09-30 13F AURINIA PHARMACEUTICALS COM Call 393,000 28.77 4,343 67.97 n/a n/a n/a
2025-08-14 2025-06-30 13F AURINIA PHARMACEUTICALS COM Call 305,200 4.48 2,585 10.09 n/a n/a n/a
2025-05-19 2025-03-31 13F/A AURINIA PHARMACEUTICALS COM Call 292,100 -22.81 2,348 -30.90 n/a n/a n/a
2025-05-14 2025-03-31 13F AURINIA PHARMACEUTICALS COM Call 292,100 2,348 n/a n/a n/a
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM Call 378,400 65.38 3,398 102.62 n/a n/a n/a
2024-11-15 2024-09-30 13F AURINIA PHARMACEUTICALS COM Call 228,800 -64.63 1,677 -54.59 n/a n/a n/a
2024-08-15 2024-06-30 13F AURINIA PHARMACEUTICALS COM Call 646,900 192.58 3,694 233.60 n/a n/a n/a
2024-05-16 2024-03-31 13F AURINIA PHARMACEUTICALS COM Call 221,100 171.29 1,108 51.23 n/a n/a n/a
2024-02-15 2023-12-31 13F AURINIA PHARMACEUTICALS COM Call 81,500 -46.24 733 -37.81 n/a n/a n/a
2023-11-15 2023-09-30 13F AURINIA PHARMACEUTICALS COM Call 151,600 67.51 1,178 34.36 n/a n/a n/a
2023-08-14 2023-06-30 13F AURINIA PHARMACEUTICALS COM Call 90,500 -66.56 876 -70.46 n/a n/a n/a
2023-05-16 2023-03-31 13F AURINIA PHARMACEUTICALS COM Call 270,600 53.66 2,966 290.13 n/a n/a n/a
2023-02-15 2022-12-31 13F AURINIA PHARMACEUTICALS COM Call 176,100 -39.88 761 -65.50 n/a n/a n/a
2022-11-15 2022-09-30 13F AURINIA PHARMACEUTICALS COM Call 292,900 -56.21 2,203 -67.22 n/a n/a n/a
2022-08-16 2022-06-30 13F AURINIA PHARMACEUTICALS COM Call 668,800 -43.10 6,721 -53.81 n/a n/a n/a
2022-05-17 2022-03-31 13F AURINIA PHARMACEUTICALS COM Call 1,175,400 -31.21 14,551 -62.76 n/a n/a n/a
2022-02-15 2021-12-31 13F AURINIA PHARMACEUTICALS COM Call 1,708,700 -1.75 39,078 1.53 n/a n/a n/a
2021-11-16 2021-09-30 13F AURINIA PHARMACEUTICALS COM Call 1,739,200 430.89 38,488 806.45 n/a n/a n/a
2021-08-16 2021-06-30 13F AURINIA PHARMACEUTICALS COM Call 327,600 130.06 4,246 129.64 n/a n/a n/a
2021-05-18 2021-03-31 13F AURINIA PHARMACEUTICALS COM Call 142,400 -22.36 1,849 -27.09 n/a n/a n/a
2021-02-17 2020-12-31 13F AURINIA PHARMACEUTICALS COM Call 183,400 286.92 2,536 263.32 n/a n/a n/a
2020-11-17 2020-09-30 13F AURINIA PHARMACEUTICALS COM Call 47,400 5.57 698 -4.38 n/a n/a n/a
2020-08-17 2020-06-30 13F AURINIA PHARMACEUTICALS COM Call 44,900 8.98 730 22.07 n/a n/a n/a
2020-05-15 2020-03-31 13F AURINIA PHARMACEUTICALS COM Call 41,200 43.06 598 2.57 n/a n/a n/a
2020-02-14 2019-12-31 13F AURINIA PHARMACEUTICALS COM Call 28,800 583 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F AURINIA PHARMACEUTICALS COM Put 19,500 -86.65 289 -87.64 n/a n/a n/a
2026-02-12 2025-12-31 13F AURINIA PHARMACEUTICALS COM Put 146,100 -1.15 2,330 42.68 n/a n/a n/a
2025-11-14 2025-09-30 13F AURINIA PHARMACEUTICALS COM Put 147,800 20.26 1,633 57.02 n/a n/a n/a
2025-08-14 2025-06-30 13F AURINIA PHARMACEUTICALS COM Put 122,900 -2.92 1,041 2.26 n/a n/a n/a
2025-05-19 2025-03-31 13F/A AURINIA PHARMACEUTICALS COM Put 126,600 -43.91 1,018 -49.80 n/a n/a n/a
2025-05-14 2025-03-31 13F AURINIA PHARMACEUTICALS COM Put 126,600 1,018 n/a n/a n/a
2025-02-14 2024-12-31 13F AURINIA PHARMACEUTICALS COM Put 225,700 42.13 2,027 74.05 n/a n/a n/a
2024-11-15 2024-09-30 13F AURINIA PHARMACEUTICALS COM Put 158,800 0.38 1,164 28.90 n/a n/a n/a
2024-08-15 2024-06-30 13F AURINIA PHARMACEUTICALS COM Put 158,200 -10.16 903 2.38 n/a n/a n/a
2024-05-16 2024-03-31 13F AURINIA PHARMACEUTICALS COM Put 176,100 327.43 882 138.38 n/a n/a n/a
2024-02-15 2023-12-31 13F AURINIA PHARMACEUTICALS COM Put 41,200 -49.88 370 -42.01 n/a n/a n/a
2023-11-15 2023-09-30 13F AURINIA PHARMACEUTICALS COM Put 82,200 -70.22 639 -76.11 n/a n/a n/a
2023-08-14 2023-06-30 13F AURINIA PHARMACEUTICALS COM Put 276,000 202.96 2,672 167.64 n/a n/a n/a
2023-05-16 2023-03-31 13F AURINIA PHARMACEUTICALS COM Put 91,100 397.81 998 1,163.29 n/a n/a n/a
2023-02-15 2022-12-31 13F AURINIA PHARMACEUTICALS COM Put 18,300 -92.17 79 -95.51 n/a n/a n/a
2022-11-15 2022-09-30 13F AURINIA PHARMACEUTICALS COM Put 233,800 27.34 1,758 -4.72 n/a n/a n/a
2022-08-16 2022-06-30 13F AURINIA PHARMACEUTICALS COM Put 183,600 -53.67 1,845 -62.39 n/a n/a n/a
2022-05-17 2022-03-31 13F AURINIA PHARMACEUTICALS COM Put 396,300 -20.76 4,906 -57.10 n/a n/a n/a
2022-02-15 2021-12-31 13F AURINIA PHARMACEUTICALS COM Put 500,100 -13.16 11,437 -10.26 n/a n/a n/a
2021-11-16 2021-09-30 13F AURINIA PHARMACEUTICALS COM Put 575,900 52.27 12,745 160.05 n/a n/a n/a
2021-08-16 2021-06-30 13F AURINIA PHARMACEUTICALS COM Put 378,200 1,265.34 4,901 1,261.39 n/a n/a n/a
2021-05-18 2021-03-31 13F AURINIA PHARMACEUTICALS COM Put 27,700 -86.27 360 -87.10 n/a n/a n/a
2021-02-17 2020-12-31 13F AURINIA PHARMACEUTICALS COM Put 201,700 365.82 2,790 337.30 n/a n/a n/a
2020-11-17 2020-09-30 13F AURINIA PHARMACEUTICALS COM Put 43,300 -26.24 638 -33.12 n/a n/a n/a
2020-08-17 2020-06-30 13F AURINIA PHARMACEUTICALS COM Put 58,700 406.03 954 467.86 n/a n/a n/a
2020-05-15 2020-03-31 13F AURINIA PHARMACEUTICALS COM Put 11,600 -67.23 168 -76.57 n/a n/a n/a
2020-02-14 2019-12-31 13F AURINIA PHARMACEUTICALS COM Put 35,400 717 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.